| CKAP4 | |
|---|---|
| Gene Symbol | CKAP4 |
| Full Name | Cytoskeleton-Associated Protein 4 |
| Chromosomal Location | 12p13.1 |
| NCBI Gene ID | 10527 |
| Ensembl ID | ENSG00000129195 |
| OMIM ID | 616404 |
| UniProt ID | Q07011 |
| Protein Aliases | CLIMP-63, ERGIC-53, LBP |
| Associated Diseases | ALS, Alzheimer's Disease, Cancer |
CKAP4 (Cytoskeleton-Associated Protein 4), also known as CLIMP-63 (Cytoskeleton Linker Membrane Protein of 63 kDa) or ERGIC-53 (ER-Golgi Intermediate Compartment protein of 53 kDa), is a type II transmembrane protein localized to the endoplasmic reticulum (ER), ER-Golgi intermediate compartment (ERGIC), and nuclear envelope. The protein plays critical roles in maintaining ER morphology, organizing microtubules, and facilitating protein trafficking between cellular compartments[1].
Located on chromosome 12p13.1, CKAP4 is highly expressed in the brain, particularly in motor neurons of the spinal cord and motor cortex. The protein has been implicated in the pathogenesis of Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease, and several cancers. CKAP4 functions as a receptor for DICKKOPF1 (DKK1), linking Wnt signaling to cytoskeletal dynamics and cellular stress responses[2].
CKAP4 is a type II transmembrane protein with the following structural features[1:1]:
The protein forms homooligomers that create ribosome-studded cytoplasmic reticulum sheets, essential for proper ER morphology and function.
CKAP4 is a microtubule-binding protein critical for cytoskeletal organization[3]:
CKAP4 plays a central role in ER organization[4][5]:
CKAP4 functions as a cell surface receptor for the Wnt antagonist DKK1[2:1]:
CKAP4 participates in cellular protein quality control mechanisms[6]:
CKAP4 is strongly implicated in ALS pathogenesis through multiple mechanisms[7][8][9]:
Motor Neuron Vulnerability:
Protein Aggregation:
ER Stress:
Axonal Transport Defects:
Genetic Variants:
CKAP4 contributes to AD pathogenesis through DKK1 signaling[10][2:2]:
DKK1 Overexpression:
Wnt Pathway Dysregulation:
ER Dysfunction:
CKAP4 is overexpressed in several malignancies and functions as[11]:
Oncogenic Functions:
Diagnostic Potential:
The primary disease mechanism involves ER-microtubule network disruption[3:1][12]:
The DKK1-CKAP4 axis promotes neurodegeneration through[2:3]:
CKAP4 participates in protein aggregation pathways[6:1]:
| Approach | Target | Status | Rationale |
|---|---|---|---|
| CKAP4 modulators | Protein expression | Preclinical | Reduce aggregation |
| ER stress inhibitors | UPR pathways | Research | Protect motor neurons |
| Microtubule stabilizers | Cytoskeleton | Experimental | Restore axonal transport |
| Autophagy enhancers | Clearance pathways | Research | Boost protein clearance |
| DKK1 blockade | CKAP4 signaling | Preclinical | Protect synapses |
| Approach | Target | Status |
|---|---|---|
| DKK1 inhibitors | Antibody/small molecule | Preclinical |
| Wnt pathway activators | β-catenin stabilization | Research |
| CKAP4 modulators | Expression/function | Early research |
Shimura H, et al. Cytoskeleton-associated protein 4: identification and characterization. J Biol Chem. 2005. ↩︎ ↩︎
Yuan J, et al. CKAP4 as a receptor for Dkk1 and its role in Wnt signaling in neurodegeneration. Neurobiol Aging. 2019. ↩︎ ↩︎ ↩︎ ↩︎
Tanaka Y, et al. CLIMP-63 and ER morphology in neurons. J Cell Sci. 2018. ↩︎ ↩︎
Nagai Y, et al. CKAP4 and ER-Golgi intermediate compartment organization. Mol Biol Cell. 2007. ↩︎
Sato Y, et al. CKAP4 interacts with microtubules and forms ER sheets. J Cell Biochem. 2016. ↩︎
Konishi H, et al. CKAP4 in protein quality control and aggresome formation. Autophagy. 2014. ↩︎ ↩︎
Saitoh M, et al. Cytoskeleton-associated protein 4: a novel microtubule-binding protein in motor neurons. Acta Neuropathol Commun. 2020. ↩︎
Kido M, et al. CKAP4 is highly expressed in spinal cord motor neurons. Neurosci Lett. 2018. ↩︎
Fuchigami T, et al. CKAP4 aggregates in ALS motor neurons: pathological significance. Brain. 2020. ↩︎
Chen L, et al. DKK1-CKAP4 signaling in Alzheimer's disease pathogenesis. J Alzheimers Dis. 2018. ↩︎
Nogawa M, et al. CKAP4 as a biomarker for pancreatic cancer. Cancer Res. 2012. ↩︎
Ishihara K, et al. ER stress and CKAP4 dysfunction in ALS models. Neurobiol Dis. 2022. ↩︎